The renaissance of psychedelics in the field of clinical research has caught widespread public attention. This podcast would provide listeners an opportunity to understand why this resurgence has occurred, what is can offer to the field of clinical psychology, and the current scope of the research to date.

Dr. Amanda Khan

Dr. Amanda Khan is a licensed clinical psychologist and researcher specializing in the assessment and treatment of trauma sequelae. Dr. Khan is a staff psychologist at Sage Integrative Health, a holistic psychedelic clinic, where she provides ketamine-assisted psychotherapy, depth oriented trauma work, and post-psychedelic integration. She served as an independent diagnostician on the Multidisciplinary Association for Psychedelic Studies (MAPS) on phase II and III trials of MDMA-enhanced psychotherapy for PTSD for four years. Dr. Khan has trained in MDMA-Assisted Therapy with MAPS and Ketamine-Assisted Psychotherapy with Polaris Insight Center, and serves as a Psilocybin Therapist on the UCSD clinical trial for phantom limb pain. Dr. Khan's program of research aims to elucidate how characteristics of trauma, emotion regulation, and biology impact the etiology, maintenance, and treatment of PTSD, moral injury, and depression/suicidality. She is especially interested in developing novel approaches, such as using psychedelics, to heal treatment-resistant PTSD. Dr. Khan is the Chair of the Moral Injury Special Interest Group (SIG) for the International Society of Traumatic Stress Studies (ISTSS). She has published numerous peer-reviewed journal articles, presents regularly at conferences, and is lead author on a chapter exploring psilocybin for trauma-related disorders. She also writes op-eds for Psychedelics Today, Stress Points, and Medium. Dr. Khan gives regular invited talks on moral injury and working with gender and sexual orientation diverse people. If you'd like to reach out to Dr. Khan visit her website http://amandakhanphd.com/